302 related articles for article (PubMed ID: 11920524)
1. Seminal vesicle involvement in patients with D1 disease predicts early prostate specific antigen recurrence and metastasis after radical prostatectomy and early androgen ablation.
Ahlering TE; Skarecky DW; McLaren CE; Weinberg AC
Cancer; 2002 Mar; 94(6):1648-53. PubMed ID: 11920524
[TBL] [Abstract][Full Text] [Related]
2. Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors.
Bloom KD; Richie JP; Schultz D; Renshaw A; Saegaert T; D'amico AV
Urology; 2004 Feb; 63(2):333-6. PubMed ID: 14972484
[TBL] [Abstract][Full Text] [Related]
3. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.
Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ
J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725
[TBL] [Abstract][Full Text] [Related]
4. Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status.
Masterson TA; Pettus JA; Middleton RG; Stephenson RA
Urology; 2005 Jul; 66(1):152-5. PubMed ID: 15992904
[TBL] [Abstract][Full Text] [Related]
5. Important preoperative prognostic factors for extracapsular extension, seminal vesicle invasion and lymph node involvement in cases with radical retropubic prostatectomy.
Ozgür A; Onol FF; Türkeri LN
Int Urol Nephrol; 2004; 36(3):369-73. PubMed ID: 15783108
[TBL] [Abstract][Full Text] [Related]
6. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.
Salomon L; Anastasiadis AG; Johnson CW; McKiernan JM; Goluboff ET; Abbou CC; Olsson CA; Benson MC
Urology; 2003 Aug; 62(2):304-9. PubMed ID: 12893340
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
[TBL] [Abstract][Full Text] [Related]
8. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
9. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
Egan AJ; Bostwick DG
Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
[TBL] [Abstract][Full Text] [Related]
10. [The meaning of PSA progression after radical prostatectomy. Preliminary results].
Luján Galán M; Pascual Mateo C; Rodríguez García N; Chiva Robles V; Escalera Almendros C; Angulo Cuesta J; Berenguer Sánchez A
Actas Urol Esp; 2006 Apr; 30(4):353-8. PubMed ID: 16838606
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
[TBL] [Abstract][Full Text] [Related]
12. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.
Blute ML; Bergstralh EJ; Iocca A; Scherer B; Zincke H
J Urol; 2001 Jan; 165(1):119-25. PubMed ID: 11125379
[TBL] [Abstract][Full Text] [Related]
13. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.
Ferrari MK; McNeal JE; Malhotra SM; Brooks JD
Urology; 2004 Oct; 64(4):749-53. PubMed ID: 15491714
[TBL] [Abstract][Full Text] [Related]
14. Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease.
Badani KK; Reddy BN; Moskowitz EJ; Paulucci DJ; Beksac AT; Martini A; Whalen MJ; Skarecky DW; Huynh LM; Ahlering TE
Urol Oncol; 2018 Jun; 36(6):310.e1-310.e6. PubMed ID: 29625782
[TBL] [Abstract][Full Text] [Related]
15. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles.
Johnson CW; Anastasiadis AG; McKiernan JM; Salomon L; Eaton S; Goluboff ET; Olsson CA; Benson MC
Urol Oncol; 2004; 22(2):107-11. PubMed ID: 15082006
[TBL] [Abstract][Full Text] [Related]
16. The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer.
D'Amico AV; Whittington R; Schnall M; Malkowicz SB; Tomaszewski JE; Schultz D; Wein A
Cancer; 1995 May; 75(9):2368-72. PubMed ID: 7536124
[TBL] [Abstract][Full Text] [Related]
17. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
Secin FP; Bianco FJ; Vickers AJ; Reuter V; Wheeler T; Fearn PA; Eastham JA; Scardino PT
Cancer; 2006 Jun; 106(11):2369-75. PubMed ID: 16649221
[TBL] [Abstract][Full Text] [Related]
18. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
19. Seminal vesicle invasion combined with extraprostatic extension is associated with higher frequency of biochemical recurrence and lymph node metastasis than seminal vesicle invasion alone: Proposal for further pT3 prostate cancer subclassification.
Rehman A; El-Zaatari ZM; Han SH; Shen SS; Ayala AG; Miles B; Divatia MK; Ketcham MS; Chung BM; Rogers JT; Ro JY
Ann Diagn Pathol; 2020 Dec; 49():151611. PubMed ID: 32956915
[TBL] [Abstract][Full Text] [Related]
20. A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy.
Pierorazio PM; Ross AE; Schaeffer EM; Epstein JI; Han M; Walsh PC; Partin AW
J Urol; 2011 May; 185(5):1691-7. PubMed ID: 21419448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
